Acting Director, Bio21 Institute, University of Melbourne; Head, Metabolomics Australia
Health & Medicine
For the first time, researchers have shown that alterations to two cell ‘pathways’ directly cause lung adenocarcinomas which could provide a breakthrough for its diagnosis and treatment